help the country to meet requirements in the future.
Once the MOU has been signed by the ministry and returned to ITI, delivery of Zithromax ® is scheduled for approximately one to two months prior to the time when MDA is to take place. For countries that are already involved and that have received Zithromax ® in past years, there needs to be an updated inventory of any drugs already in the country, including those with a short shelf life and those about to expire. On the basis of this information, adjustments to the donation forecast are made.
Supply chain
Currently, Zithromax ® is manufactured in two formulations, pediatric powder for oral suspension for children ages six months to fi ve years, and tablets for people over fi ve years of age. The product is manufactured at various sites in Europe or the USA. Once manufactured, the product is stored in one of Pfi zer's European warehouse locations where the goods await allocation to recipient countries. Due to the large size of each shipment (hundreds of pallets for each country), several airplane loads may be required. Upon arrival in the country, the ministry of health must ensure customs clearance and transport to central medical stores and to regional warehouses in preparation for MDA. All charges are the responsibility of the ministry of health. A detailed description of best practices for in-country supply chain can be found in "Zithromax ® in the Elimination of Blinding Trachoma: A Program Manager's Guide" at www.trachoma.org/guides-and-manuals
Countries seeking Zithromax ®
The Zithromax ® donation is available only to governments of poor endemic countries for the elimination of blinding trachoma. Countries that have been approved for the donation may use it for MDA, administration after trichiasis surgery, or as part of surveillance or prevalence surveys, in addition to special pre-approved uses by ITI and the TEC.
National ownership and proven commitment to the elimination goal is key for a successful application and continued donation of Zithromax ® . The requirements for Zithromax ® donation (including evidence of need, training of health care staff, SAFE strategy implementation, effective distribution strategies, and monitoring and evaluation) may be demanding for underresourced and overstretched national health programmes. However, they are necessary to manage and monitor the Zithromax ® donation to aid in the elimination of this painful and blinding disease. We have found that using a cigarette lighter for heating is a viable alternative.
In Tanzania, the cigarette lighter illustrated is easily available and can be purchased cheaply from local stores, costing only TZS 500 (around US $0.30). The fl ame effectively heats the ball of the Wordsworth cautery, and soot accumulation can be avoided if the cautery is held in the blue rather than the yellow part of the fl ame.
So far, we have tested two models of cheap lighter. Not all are suitable, as the top of the lighter becomes hot and parts may melt during prolonged use. For this reason also we recommend that surgical gloves are not worn by the person holding the lighter. When using a lighter of the type illustrated, we have found this method to be safe, easy to operate, and effective both in our own theatre and on outreach.
Using a lighter will also reduce the risks of fi re in the theatre caused by gowns or drapes coming in contact with the fl ame of an unattended spirit lamp, when operator or assistant are absorbed by a challenging operation. I have seen this once: surgical gowns are surprisingly fl ammable! In general anaesthetic situations, the usual precautions regarding infl ammable gases and naked fl ames should be observed.
brian Savage Ophthalmologist, Haydom and KCMC Hospitals, Tanzania.
Using a lighter to heat a cautery
Examples of the lighter we have found effective
Wordsworth cautery being heated in blue part of the fl ame. (the fl ame here is turned much higher than normal for illustration purposes)
